Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
fujdJduH1R4w2UVh
